X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DIVIS LABORATORIES - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DIVIS LABORATORIES PFIZER/
DIVIS LABORATORIES
 
P/E (TTM) x 31.0 28.8 107.6% View Chart
P/BV x 4.9 5.0 98.8% View Chart
Dividend Yield % 0.7 1.0 66.2%  

Financials

 PFIZER   DIVIS LABORATORIES
EQUITY SHARE DATA
    PFIZER
Mar-16
DIVIS LABORATORIES
Mar-17
PFIZER/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,7241,222 222.9%   
Low Rs1,611784 205.5%   
Sales per share (Unadj.) Rs440.9153.1 288.0%  
Earnings per share (Unadj.) Rs48.739.9 121.9%  
Cash flow per share (Unadj.) Rs75.844.6 169.9%  
Dividends per share (Unadj.) Rs15.0010.00 150.0%  
Dividend yield (eoy) %0.71.0 69.4%  
Book value per share (Unadj.) Rs462.9201.8 229.4%  
Shares outstanding (eoy) m45.75265.47 17.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.96.6 75.0%   
Avg P/E ratio x44.525.1 177.3%  
P/CF ratio (eoy) x28.622.5 127.2%  
Price / Book Value ratio x4.75.0 94.2%  
Dividend payout %30.825.0 123.0%   
Avg Mkt Cap Rs m99,163266,266 37.2%   
No. of employees `0002.99.7 29.7%   
Total wages/salary Rs m2,7584,687 58.8%   
Avg. sales/employee Rs Th6,981.74,175.0 167.2%   
Avg. wages/employee Rs Th954.5481.5 198.2%   
Avg. net profit/employee Rs Th771.11,089.3 70.8%   
INCOME DATA
Net Sales Rs m20,17040,643 49.6%  
Other income Rs m857749 114.5%   
Total revenues Rs m21,02841,392 50.8%   
Gross profit Rs m4,31014,460 29.8%  
Depreciation Rs m1,2391,233 100.4%   
Interest Rs m523 23.0%   
Profit before tax Rs m3,92313,953 28.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7943,349 53.6%   
Profit after tax Rs m2,22810,604 21.0%  
Gross profit margin %21.435.6 60.1%  
Effective tax rate %45.724.0 190.5%   
Net profit margin %11.026.1 42.3%  
BALANCE SHEET DATA
Current assets Rs m16,29940,105 40.6%   
Current liabilities Rs m7,5946,595 115.2%   
Net working cap to sales %43.282.5 52.3%  
Current ratio x2.16.1 35.3%  
Inventory Days Days65119 55.1%  
Debtors Days Days2681 31.9%  
Net fixed assets Rs m8,62219,995 43.1%   
Share capital Rs m458531 86.2%   
"Free" reserves Rs m20,72253,043 39.1%   
Net worth Rs m21,18053,574 39.5%   
Long term debt Rs m250-   
Total assets Rs m29,13761,585 47.3%  
Interest coverage x755.5618.4 122.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.7 104.9%   
Return on assets %7.717.3 44.4%  
Return on equity %10.519.8 53.1%  
Return on capital %19.026.1 72.8%  
Exports to sales %0.10-   
Imports to sales %17.525.2 69.2%   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,52610,259 34.4%   
Fx inflow Rs m5235,384 0.1%   
Fx outflow Rs m14010,399 1.3%   
Net fx Rs m-8824,985 -0.4%   
CASH FLOW
From Operations Rs m3,43611,493 29.9%  
From Investments Rs m-6,991-11,372 61.5%  
From Financial Activity Rs m-619-93 664.7%  
Net Cashflow Rs m-4,17428 -14,695.4%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 11.8 63.6%  
FIIs % 4.9 19.0 25.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.2 137.8%  
Shareholders   85,207 31,796 268.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Feb 21, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS